Search Results - "Asmuth, D M"

Refine Results
  1. 1

    HIV neuropathy natural history cohort study : Assessment measures and risk factors by SIMPSON, D. M, KITCH, D, DIAZ-ARRASTIA, R, SHRIVER, S, MILLAR, L, CLIFFORD, D. B, EVANS, S. R, MCARTHUR, J. C, ASMUTH, D. M, COHEN, B, GOODKIN, K, GERSCHENSON, M, SO, Y, MARRA, C. M

    Published in Neurology (13-06-2006)
    “…Distal sensory polyneuropathy (DSP) is the most common neurologic complication of human immunodeficiency virus (HIV) infection. Risk factors for DSP have not…”
    Get full text
    Journal Article
  2. 2

    Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy by ZHOU, L, KITCH, D. W, GOODKIN, K, MILLAR, L, SHRIVER, S, ASMUTH, D. M, CLIFFORD, D. B, SIMPSON, D. M, MCARTHUR, J. C, EVANS, S. R, HAUER, P, RAMAN, S, EBENEZER, G. J, GERSCHENSON, M, MARRA, C. M, VALCOUR, V, DIAZ-ARRASTIA, R

    Published in Neurology (12-06-2007)
    “…To demonstrate the relationship between epidermal nerve fiber density (ENFD) in the leg and the phenotype of HIV-associated distal sensory polyneuropathy…”
    Get full text
    Journal Article
  3. 3

    Clinical Features of Microsporidiosis in Patients with AIDS by Asmuth, David M., DeGirolami, Paola C., Federman, Micheline, Ezratty, Caroline R., Pleskow, Douglas K., Desai, Gautam, Wanke, Christine A.

    Published in Clinical infectious diseases (01-05-1994)
    “…Microsporidia are protozoan parasites responsible for significant gastrointestinal disease in patients infected with human immunodeficiency virus. We report…”
    Get full text
    Journal Article
  4. 4

    Treatments for Hepatitis B by Saravolatz, Louis D., Asmuth, David M., Nguyen, Hien H., Melcher, Gregory P., Cohen, Stuart H., Pollard, Richard B.

    Published in Clinical infectious diseases (01-11-2004)
    “…New optimism surrounds treatments for chronic hepatitis B (CHB). Interferon-α, lamivudine, and adefovir dipivoxil are currently approved by the United States…”
    Get full text
    Journal Article
  5. 5

    Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients by Seshadri, C, Uiso, L O, Ostermann, J, Diefenthal, H, Shao, H J, Chu, H Y, Asmuth, D M, Thielman, N M, Bartlett, J A, Crump, J A

    Published in East African medical journal (01-09-2008)
    “…To evaluate the performance of QuantiFERON-TB GOLD (QFTG) in a resource-poor setting among patients with and without HIV infection. Cross-sectional study. Two…”
    Get full text
    Journal Article
  6. 6

    Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature by Rossero, R, Asmuth, D M, Grady, J J, McKinsey, D S, Green, S, Andron, L, Pollard, R B

    Published in International journal of STD & AIDS (01-05-2003)
    “…The safety and efficacy of hydroxyurea with didanosine in combination with stavudine in nucleoside reverse-transcriptase inhibitor (NRTI)-experienced patients…”
    Get more information
    Journal Article
  7. 7

    Physiological effects of HIV infection on human intestinal epithelial cells: an in vitro model for HIV enteropathy by Asmuth, D M, Hammer, S M, Wanke, C A

    Published in AIDS (London) (01-02-1994)
    “…To determine the role of direct infection of intestinal cells with HIV-1 in the pathogenesis of HIV-related enteropathy. We infected HT-29-18-C1 intestinal…”
    Get more information
    Journal Article
  8. 8

    Changing Patterns of Infections in Patients with AIDS: A Study of 279 Autopsies of Prison Inmates and Nonincarcerated Patients at a University Hospital in Eastern Texas, 1984–1993 by Lyon, Robert, Haque, Abida K., Asmuth, David M., Woods, Gail L.

    Published in Clinical infectious diseases (01-08-1996)
    “…Reports on autopsies of 279 persons infected with human immunodeficiency virus (HIV) were reviewed retrospectively to determine changes in survival rates and…”
    Get full text
    Journal Article
  9. 9

    Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques by Asmuth, D M, Abel, K, George, M D, Dandekar, S, Pollard, R B, Miller, C J

    Published in Journal of medical primatology (01-02-2008)
    “…In vitro and clinical observations in HIV-infected patients receiving interferon alpha therapy have shown a reduction in HIV loads. Limited investigations have…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cytomegalovirus Glycoprotein B Groups in Human Immunodeficiency Virus–Infected Patients with Incident Retinitis by Drew, W. Lawrence, Chou, Sunwen, Miner, Richard C., Mohr, Beth A., Busch, Michael P., van der Horst, Charles M., Asmuth, David M., Kalish, Leslie A.

    Published in The Journal of infectious diseases (01-07-2002)
    “…Cytomegalovirus (CMV) strains may be categorized into 4 different groups on the basis of glycoprotein B (gB) genotype. gB genotypes in CMV polymerase chain…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384 by Robbins, Gregory K., Spritzler, John G., Chan, Ellen S., Asmuth, David M., Gandhi, Rajesh T., Rodriguez, Benigno A., Skowron, Gail, Skolnik, Paul R., Shafer, Robert W., Pollard, Richard B.

    Published in Clinical infectious diseases (01-02-2009)
    “…Background. Initiation of combination antiretroviral therapy (ART) results in higher total CD4 cell counts, a surrogate for immune reconstitution. Whether the…”
    Get full text
    Journal Article
  14. 14

    Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection by Asmuth, David M, Busch, Michael P, Laycock, Megan E, Mohr, Beth A, Kalish, Leslie A, van der Horst, Charles M

    Published in Antiviral research (01-08-2004)
    “…Chronic infection with either hepatitis B (HBV) or hepatitis C virus (HCV) is frequently present in patients seropositive for human immunodeficiency virus…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Effects of Clostridium perfringens Recombinant and Crude Phospholipase C and θ-toxin on Rabbit Hemodynamic Parameters by Asmuth, David M., Olson, Richard D., Hackett, Sean P., Bryant, Amy E., Tweten, Rodney K., Tso, J. Yun, Zollman, Ted, Stevens, Dennis L.

    Published in The Journal of infectious diseases (01-11-1995)
    “…Clostridium perfringens exotoxins have been implicated as major virulence factors responsible for shock and organ failure in gas gangrene, yet the mechanism(s)…”
    Get full text
    Journal Article
  18. 18

    HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy by IMAMICHI, Hiromi, DEGRAY, Gerald, ASMUTH, David M, FISCHL, Margaret A, LANDAY, Alan L, LEDERMAN, Michael M, SERETI, Irini

    Published in AIDS (London) (14-01-2011)
    “…administration of recombinant human interleukin (IL)-7 leads to CD4 and CD8 T-cell expansions in HIV-infected individuals, demonstrating promising capacity for…”
    Get full text
    Journal Article
  19. 19

    CD4+ T-Cell Restoration After 48 Weeks in the Maraviroc Treatment-Experienced Trials MOTIVATE 1 and 2 by Asmuth, David M, Goodrich, James, Cooper, David A, Haubrich, Richard, Rajicic, Natasa, Hirschel, Bernard, Mayer, Howard, Valdez, Hernan

    “…OBJECTIVES:To determine factors associated with CD4 responses to maraviroc (MVC)-containing regimens in treatment-experienced patients…”
    Get full text
    Journal Article
  20. 20